ZX-7101A
- Generic Name
- ZX-7101A
Study to Assess the Safety and Efficacy of ZX-7101A in Children Aged 5-11 Years with Influenza
- Conditions
- Respiratory Viral Infection
- Interventions
- First Posted Date
- 2024-11-01
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Nanjing Zenshine Pharmaceuticals
- Target Recruit Count
- 180
- Registration Number
- NCT06669351
- Locations
- 🇨🇳
Baoding Hospital of Beijing Children's Hospital, Capital Medical University, Baoding, Hebei, China
🇨🇳West China Second University Hospital, Sichuan University, Chengdu, Sichuan, China
🇨🇳Children's Hospital Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
Study to Assess the Safety and Efficacy of ZX-7101A in Adolescents with Influenza
- First Posted Date
- 2023-10-25
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Nanjing Zenshine Pharmaceuticals
- Target Recruit Count
- 361
- Registration Number
- NCT06099873
- Locations
- 🇨🇳
Fudan University affiliated Huashan Hospital, Shanghai, Shanghai, China
A Study to Evaluate Drug-drug Interaction of ZX-7101A Tablets and Oseltamivir Phosphate Capsules in Healthy Adult Subjects
- Conditions
- Drug Interaction
- Interventions
- First Posted Date
- 2023-09-28
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Nanjing Zenshine Pharmaceuticals
- Target Recruit Count
- 18
- Registration Number
- NCT06057103
- Locations
- 🇨🇳
Peking University Third Hospital, Beijing, Beijing, China
A Study to Evaluate the Effect of a Single Oral Dose of ZX-7101A on the QTc Interval in Healthy Subjects
- First Posted Date
- 2023-07-20
- Last Posted Date
- 2024-11-04
- Lead Sponsor
- Nanjing Zenshine Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT05955027
- Locations
- 🇨🇳
Huashan Hospital affiliated to Fudan University, Shanghai, Shanghai, China
A Study to Assess the Effect of Itraconazole Capsules on the Pharmacokinetics of ZX-7101A Tablets in Healthy Adult Subjects in China
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Nanjing Zenshine Pharmaceuticals
- Target Recruit Count
- 16
- Registration Number
- NCT05949385
- Locations
- 🇨🇳
Huashan Hospital affiliated to Fudan University, Shanghai, Shanghai, China
A Study to Evaluate the Efficacy and Safety of ZX-7101A Tablets in Adults with Uncomplicated Influenza
- First Posted Date
- 2023-01-27
- Last Posted Date
- 2024-11-05
- Lead Sponsor
- Nanjing Zenshine Pharmaceuticals
- Target Recruit Count
- 900
- Registration Number
- NCT05702489
- Locations
- 🇨🇳
Zhongshan Hospital Affiliated to Fudan University, Shanghai, China
Study to Assess the Safety, Tolerability and Pharmacokinetics of ZX-7101A and the Food Effect in Healthy Volunteers
- Conditions
- Safety IssuesTolerancePharmacokineticsFood Effect
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-02-01
- Last Posted Date
- 2023-07-21
- Lead Sponsor
- Nanjing Zenshine Pharmaceuticals
- Target Recruit Count
- 66
- Registration Number
- NCT05217732
- Locations
- 🇨🇳
Fudan University affiliated Huashan Hospital, Shanghai, Shanghai, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.